The molecular circuitry directing tissue development and homeostasis is hardwired by genetic programs but may also be subject to fine-tuning or major modification by environmental conditions. It remains unclear whether such malleability is at work-particularly in tissues directly in contact with the environment-and contributes to their optimal maintenance and resilience. The protein kinase p38 is activated by physiological cues that signal tissue damage and neoplastic transformation. Here, we found that p38 phosphorylated and thereby destabilized p63, a transcription factor essential for epidermal development. Through this regulatory mechanism, p38 limited the frequency of keratinocytes with stem cell properties and tumorigenic potential. Correspondingly, epidermal loss of p38 expression or activity promoted or correlated with carcinogenesis in mouse and human skin, respectively. Genetic mouse models revealed a tumorigenic mechanism from p38 loss through p63-mediated suppression of the matrix metalloprotease MMP13. These findings illustrate a previously uncharacterized epidermal tumor-suppressive mechanism in which stress-activated signaling induces the contraction of stem cell-like keratinocyte pools.
INTRODUCTION
Barrier tissues such as the skin have relatively high epithelial turnover rates and require stem and progenitor cells (SPCs) to constantly replenish cells lost because of exfoliation or injury (1, 2) . The skin epithelium, or epidermis, comprises strata of stem/progenitor-like, proliferative, and differentiated keratinocytes that are positioned in a gradient of maturation. Epidermal SPCs are prone to acquisition and accumulation of oncogenic mutations: They are accessible to solar radiation and other environmental carcinogens and reside in the skin much longer than their transient progenies. Besides, mutations in SPCs are propagated more widely than those in the epidermal strata of later differentiation stages. Hence, cell-autonomous mechanisms suppressing skin carcinogenesis are particularly important and can become most effective in the SPC population. Few such mechanisms, however, have been demonstrated to date.
The protein kinase p38 was originally found because of its binding affinity for anti-inflammatory compounds (3) and its responsiveness to cytokines and microbial products (4) (5) (6) and has since been investigated as a driver and regulator of immune responses. Subsequent studies revealed that p38 was also activated by tissuedamaging and tumor-promoting stimuli and mediated cellular interpretation of them (7) (8) (9) . It was found that conditional ablation of the p38 gene in mice resulted in hyperplasia and enhanced carcinogenesis in airway and intestinal epithelia as well as in hepatic parenchyma (10) (11) (12) (13) . It remains unclear how p38 signaling exerts control over tissue homeostasis and tumorigenesis and whether cell typespecific mechanisms are involved in this control.
In this study, we identified the role of p38 in SPC homeostasis in the stratified epithelium of the skin and its link to skin carcinogenesis. Furthermore, we found that p63, a master transcription factor governing the development and maintenance of the skin epithelium, is a key regulatory target of p38 signaling.
RESULTS

Implications of intratumoral p38 activity for barrier tissue cancers
Tumors growing on cutaneous and mucosal surfaces are constantly exposed to environmental p38-activating stimuli. We analyzed The Cancer Genome Atlas (TCGA) dataset to gauge the importance of p38 activation for the clinical outcomes of human patients with cancers of the skin and the ectodermal glandular, aerodigestive, respiratory, gastrointestinal, and lower genitourinary sites. The patients in each cancer type were divided into two groups based on their reverse-phase protein array (RPPA) signals (14) for intratumoral phosphorylated (p-) p38, a measure of p38 activation. The survival rates of the two groups, "p-p38 high" and "p-p38 low" (the 50th percentile as the cutoff), were different in some but not all cancer types (Fig. 1A) . The p-p38 high groups exhibited prolonged survival compared to the p-p38 low counterparts, most significantly in lung squamous cell carcinoma (SCC) and esophageal carcinoma (Fig. 1 , B and C). We next examined p38 phosphorylation in tissues representing early stages of skin SCC, a cancer type for which TCGA data did not exist. Most skin biopsies with a diagnosis of actinic keratosis (AK), a preneoplastic lesion that can progress to SCC, displayed epidermal p-p38 signals; in many SCC biopsies, however, p38 phosphorylation was drastically diminished in the tumor parenchyma (Fig. 1, D and E). The association between AK-to-SCC progression and the loss of p38 activity, along with the clinical benefit of intratumoral p38 activity observed in the TCGA dataset, prompted us to verify the tumorsuppressive role of p38 signaling in mice and pursue the underlying mechanisms.
Effects of p38 gene ablation on skin carcinogenesis
We generated mice in which deletion of the p38 gene was targeted to skin epithelial cells (p38K) and subjected them to a skin carcinogenesis protocol that involved the chemical carcinogen 7,12-dimethyl-benz[a]anthracene (DMBA) and the chemical irritant 12-O-tetradecanoylphorbol-13 acetate (TPA). p38K mice displayed a higher incidence of tumor development compared with wild-type (WT) mice (Fig. 2, A and B) . The two groups of mice 2 of 10 began to develop tumors at similar time points, but thereafter, tumor incidence rose faster in the p38K group. All tumors observed in WT and p38K mice were papillomas; none of them underwent malignant progression during our chemical carcinogenesis experiment. Tumors from WT mice contained proliferating cells that were localized along the tumor-stroma boundary (Fig. 2C, left) . By contrast, p38K tumors exhibited broader areas of proliferation across tumor sections (Fig. 2C, right) , suggesting an expansion of the SPClike tumor-sustaining cell pool. WT tumors retained a stratified epidermal structure and contained large cells expressing the differentiation marker KRT1, whereas p38K tumors did not manifest this phenotype (Fig. 2D) . Furthermore, p38K but not WT mice had extensive peritumoral vascularization and Ly6G + myeloid cell infiltration (Fig. 2 , E and F), which was notable in light of the previous findings that chemically induced skin tumors harbored tumor-sustaining cells that instigated the formation of tumor-associated vasculature (15) and that tumor-associated myeloid cell frequency correlates with tumor stemness (16) . Intratumoral CD3 + T cell densities were similar in WT and p38K mice (Fig. 2G) .
Inflammation promotes tumorigenesis, including in mouse models of skin carcinogenesis (17, 18) . We examined whether keratinocyte-specific p38 deficiency enhanced inflammatory responses to TPA. Similar extents of acanthosis (epidermal thickening), edema formation (dermal thickening), and leukocyte infiltration were observed in TPA-treated WT and p38K skin ( fig. S1 , A to C). The expression of molecular markers of inflammation in p38K skin was comparable to or lower than that in WT skin ( fig. S1D) . Therefore, the higher cancer susceptibility of p38K skin was not likely due to an increase in TPA-induced tumor-promoting inflammation. Effects of p38 gene ablation on epidermal regeneration Tumorigenesis and wound healing entail similar tissue remodeling processes and are driven by overlapping molecular mechanisms (19) . This resemblance is in part attributable to their shared reliance on SPC activity. To determine the effect of epidermal p38 deficiency on skin wound repair, we created punch-biopsy wounds in WT and p38K mice. Macroscopically, wound closure was moderately more efficient in p38K than WT mice until 5 days after wounding (Fig. 3, A and B) , a time point around which dermal granulation tissue begins to contract, pulling together the wound margins and obfuscating the impact, if any, of concomitant epithelial events. Histological analysis, however, revealed a notable difference in reepithelialization rate between the two animal groups: 24 hours after wounding, the leading edge of regenerating epidermis was rapidly penetrating the open wound area underneath the eschar in all p38K mice examined, whereas re-epithelialization had barely started in WT mice (Fig. 3, C to E) . The linear speed of re-epithelialization in WT skin was ~3-fold less than that in p38K skin (50 and 178 m/ hour on average, respectively).
Effects of p38 gene ablation on epidermal SPC frequency Seeking explanations for enhanced carcinogenesis and epidermal regeneration in p38K skin, we examined its epidermis for signs of increased SPC frequency. In contrast to the wealth of knowledge about hair follicle stem cells, little definitive information is available that would enable the detection of interfollicular epidermal SPCs based on their molecular properties or microanatomical locations. Our analysis was therefore directed toward keratinocytes with functional properties of SPCs. The skin of adult p38K mice harbored greater numbers of cells that, when plated and grown in culture, gave rise to holocolonies, large clonal aggregates derived from cells with sustained proliferative potential (Fig. 4, A Of note, interfollicular epidermal label retention lasted for at least 15 days in our experimental condition but was not observed when we used a protocol with a longer chase period (70 days) optimized for detecting hair follicle stem cells in the mouse tail skin (23), suggesting a relatively high proliferative state of interfollicular epidermal SPCs. Together, these observations indicated that p38 functioned to limit the size of the epidermal SPC pool and that elimination of this regulatory mechanism resulted in their expansion.
Effects of p38 gene ablation on p63 protein abundance
To obtain clues about the molecular mechanism linking p38 signaling to epidermal SPC maintenance, we examined the effect of p38 deficiency on a panel of transcription factors dictating the identity and fate of skin epithelium. The amounts of Np63 protein, the most abundant p63 isoform in the epidermis, were higher in p38K than WT keratinocytes under a steady-state culture condition and after stimulation with TPA ( Fig. 5A ). Calciuminduced differentiation, ultraviolet-B (UVB) radiation exposure, and anisomycin treatment, all of which induced p38 activation, resulted in decreased Np63 amounts in mouse keratinocytes, yet these responses were greatly attenuated in the absence of p38 (Fig. 5 , B and C). Np63 amount in human keratinocytes was also reduced upon anisomycin treatment (Fig. 5D ). This response was blocked by pharmacological inhibition of TAK1 (upstream of and necessary for p38 activation) or p38 but not c-Jun N-terminal kinase (JNK) (downstream of TAK1 and activated in parallel with p38). The effect of inhibiting these protein kinases on p38 signaling in human keratinocytes was mirrored by the extent of phosphorylation of MK2, a substrate of p38 (Fig. 5D ). p63 is a master transcription factor for epidermal SPC gene expression and plays a pivotal role in the development of stratified epithelia and ectodermal appendages (24) (25) (26) , oncogene-induced keratinocyte transformation (27) , and SCC cell survival (28, 29) . The p63-expressing basal epidermal layer was markedly expanded in both unprovoked and TPA-treated p38K skin (Fig. 5E ). Skin tumors from p38K mice exhibited the distribution of p63 + cells across entire intratumoral areas, which contrasted with their restricted occurrence in WT tumors (Fig. 5F ). KRT15 + regenerating epidermis in the wound skin of p38K mice was hyperproliferative and contained expanded p63 + cell populations (Fig. 5G ). The differences in p63 expression in WT and p38K cells were not due to changes in mRNA amount ( fig. S3) , suggesting control at the protein level.
Analysis of the TCGA RNA-sequencing dataset revealed cancer type-specific p63 expression, with the highest expression in SCC of the head and neck, lung, cervix, and esophageal carcinoma ( fig. S4A ). We also observed intense p63-specific immunofluorescence signals from the parenchyma of human SCC ( fig. S4B ). These human cancer types with high p63 expression partially overlapped with those in which intratumoral p38 activity was associated with clinical outcomes (Fig. 1, A and E) . In human AK epidermis, p63 expression was spatially excluded from areas with strong p38 phosphorylation (Fig. 5H) . Similarly, p63 protein amounts examined in a large set of human cancer cell lines (30) were inversely correlated with phosphorylated p38 signals ( fig. S4C ). Together, our findings indicated that p38 signaling exerted control on p63 protein abundance in mouse and human cells.
Phosphorylation and destabilization of p63 by p38
We tested whether p38 limited p63 protein abundance by direct phosphoryl ation. p38 was able to phosphorylate Np63 in a reaction involving purified recombinant proteins and ATP (Fig. 6A) . To examine the effect of p38 hyperactivity on Np63 in cells normally devoid of its expression, we ectopically expressed in 293T cells Np63 together with p38 CA , a p38 mutant locked in an active state due to amino acid substitutions [Asp 176 to Ala (D176A) and Phe 327 to Ser (F327S)]. In this setting, p38 hyperactivity led to a precipitous decline in Np63 amounts, which was prevented by the proteasome inhibitor MG132 (Fig. 6B) . The Np63 protein spared from destruction manifested a slightly decreased electrophoretic mobility, possibly indicative of phosphorylation. Together, our findings suggested that p38, through its basal and stimulusinduced kinase activity, modulated Np63 protein turnover by signaling proteasomemediated degradation of Np63.
We mapped the p38-phosphorylated residues in Np63 by endoproteinase digestion and mass spectrometry of the samples recovered from an in vitro kinase reaction and immunoprecipitated from an extract of MG132-treated 293T cells (Fig. 6 , A and C, and table S1). In addition, we performed immunoblot analysis using phosphorylation-specific p63 antibodies to examine some consensus p38 target sites whose phosphorylation would likely escape detection by mass spectrometry because of the lack of nearby endoproteinase cleavage sites ( fig. S5) ) targeted for phosphorylation by p38 (Fig. 6D) . We generated a series of lentiviruses expressing Np63 variants in which individual phosphoacceptor residues were removed by sitedirected mutagenesis. The turnover rates of these proteins in transduced human KERT keratinocytes were determined by tracking their decay after blocking de novo protein synthesis with cycloheximide. Substitution of Ser 66/68 , Thr 123 , and Ser 301 to nonphosphorylatable Ala prolonged the half-life of Np63 (Fig. 6, E and F) . Phosphorylation of Np63 at Ser 66/68 and of TAp63 (a p63 isoform with an alternative, long N-terminal domain) at the corresponding site occurred in 293T cells expressing p38 CA or a constitutively active form of mitogen-activated protein kinase (MAPK) kinase 6 (MKK6), a kinase immediately upstream of p38 (Fig. 6G) . Furthermore, AK epidermis exhibited immunostaining signals for Ser 66/68 -phosphorylated p63, but their intensity diminished in SCC specimens (Fig. 6, H and I) , an observation paralleling the patterns of p38 phosphorylation (Fig. 1D) .
Regulation of p63 target gene expression by p38
Given the capacity of p38 to modulate p63 availability, we examined its impact on the gene expression program in keratinocytes. Global gene expression profiling identified genes whose expression, either constitutive or UVB-inducible, was attenuated by p38 deficiency (Fig. 7A) . Many of these p38-dependent genes were functionally related to epidermal homeostasis, inflammation, and cancer and included Mmp13, S100a8, S100a9, Il1a, and Ptgs2. Their induction in response to TPA and interleukin-1 (IL-1) was also dependent on p38 ( fig. S6 ).
On the basis of the diverse functions of matrix metalloproteinase (MMP) family proteins in tissue remodeling and tumorigenesis (31, 32), we suspected the involvement of MMP13 in mediating the tumor-suppressive function of p38 and subjected the mechanism regulating its expression to scrutiny. Similar to p38-deficient keratinocytes, p38K tumors showed decreased MMP13 expression (Fig. 7B) . To demonstrate that p38 signaling drove MMP13 expression through reducing p63 availability, we determined the effect of loss of p63 on MMP13 expression. Given the essentiality of p63 in keratinocyte identity, proliferation, and survival, complete ablation of p63 expression might not permit the investigation of viable keratin ocytes, preserving their original phenotype. To bypass this potential problem, we used a small hairpin RNA (shRNA)-mediated gene knockdown (KD) approach, which could reduce but not completely abolish p63 gene (Trp63) expression. p63 KD resulted in an enhancement in TPA-induced MMP13 expression in p38K keratinocytes, restoring its magnitude to that of WT keratinocytes (Fig. 7C) . The analysis of chromatin immunoprecipitation-sequencing data illustrating genome-wide p63 occupancy in human keratinocytes [Gene Expression Omnibus (GEO) GSE59827] (33) revealed p63 binding near the MMP13 gene and in the genomic loci of other p38 target gene homologs ( fig. S7A) . Further, KD of the p63 gene led to increased MMP13 expression in human keratinocytes ( fig.  S7 , B and C), indicating a conserved role for p63 in repressing epidermal MMP13 expression in mice and humans. Last, we examined skin cancer development in Mmp13-knockout (KO) mice. In a chemical carcinogenesis experiment, tumors developed much faster and with a higher incidence in MMP13-KO relative to WT mice (Fig. 7, D and E).
DISCUSSION
We have shown that p38 signaling suppresses skin carcinogenesis and wound skin re-epithelialization and restrains the size of the epidermal SPC pool. Mechanistically, p38 serves as a molecular switch for p63 protein turnover and the reprogramming of p63-governed gene expression in the epidermis. Our findings represent a previously unidentified mechanism that enables modification of epidermal-intrinsic genetic circuitry by external stimuli and a stress-activated intracellular signaling cascade. Similar mechanisms are likely to operate in other tissues and exert a key control at the nexus of tissue development, homeostasis, and tumorigenesis.
Earlier studies sought to identify the role of p38 in skin carcinogenesis using transgenic mice expressing a dominant-negative p38 mutant (Thr 180 to Ala and Tyr 180 to Ala; 34, 35) and the small-molecule p38 inhibitor SB203580 (36) yet yielded incongruous findingsthe dominant-negative mutant diminishing and the inhibitor enhancing tumorigenesis. Decreased activation of the transcription factor activating protein 1 and increased reactive oxygen species production by the NADPH (reduced form of nicotinamide adenine dinucleotide phosphate) oxidase NOX2 were proposed as possible explanations for diminished and enhanced tumorigenesis in the respective studies. Our study used mice in which the p38 gene was specifically ablated in keratinocytes. These different experimental approaches as well as other dissimilarities between our and the earlier studies, such as the carcinogenesis protocols used (chemically induced versus UV-induced) and the genetic back grounds of mice (C57BL/6 versus SKH-1), may have led to contrasting conclusions about the in vivo effects and molecular changes resulting from loss of p38 function.
It has been shown that DMBA-TPAinduced papillomas in C57BL/6 mice rarely undergo malignant conversion (37) . None of the papillomas formed in WT and p38K mice, which were in a C57BL/6 background, progressed to SCC or other malignant forms of skin cancer during our chemical carcinogenesis experiment. Therefore, although p38 deficiency enhanced tumor initiation, it did not appear to overcome the constraints imposed by the C57BL/6 genotype that limited malignant conversion. To address whether p38 plays a role in tumor progression independently of its role in tumor initiation, it will be necessary to generate and investigate an inducible p38-KO mouse line in a genetic background prone to malignant conversion.
The transcriptional function of p63 is essential for driving epidermal SPC cycling and preventing their senescence (26, 38, 39) , particularly under conditions of oncogene activation (27) . A genomewide association study (GWAS) of skin SCC found that genetic variation at the TP63 locus (rs6791479) was associated with the risk of this cancer type (40), a finding replicated in another independent GWAS study (41) . Similar genetic evidence linking p63 to cancer susceptibility in human populations exists for bladder, lung, and pancreatic cancers (42) (43) (44) . Unlike somatic gene mutations, deletions, and amplifications that drive clonal neoplastic transformation, GWASidentified genetic variations may increase cancer risk by creating conditions that predispose normal tissues to cancer development. It remains to be determined whether p63 genetic variants associated with cancer susceptibility serve to produce such predispositions by elevating the frequency of SPCs that could become tumor-initiating cells after acquiring oncogenic genetic alterations.
Our study has demonstrated that phosphorylation by p38 enhances steady-state turnover and stimulus-induced degradation of p63. The three p38-phosphorylated sites, Ser 66/68 , Thr
123
, and Ser 301 , were found to play a role in destabilizing Np63 protein. This phosphorylation-dependent regulatory mechanism appears to be crucial for reprogramming p63-governed gene expression in the epidermis. In particular, p38 permits MMP13 gene induction by relieving p63-mediated transcriptional repression. p38 is an actionable signal transducer, amenable to inhibition and activation by small molecules. Pharmacological modulation of p38 signaling may serve as a novel approach to directed modification of epidermal and cancer stem cell phenotype for translation in regenerative medicine and clinical oncology. Most of the known functions of MMPs in cancer are related to creating a tissue microenvironment conducive to tumor growth and progression by processing extracellular matrix proteins or cell-surface molecules. There is some evidence, however, that MMPs also serve antitumor functions (45) . Our study presents a previously unidentified tumor-suppressive function of MMP13 and beckons further investigation about its action mechanisms. In our DMBA-TPA skin tumorigenesis experiments, MMP13-KO mice exhibited far greater tumor incidence and multiplicity than p38K mice. This discrepancy may be due to a difference in the extent of ablation of epidermal MMP13 expression. MMP13 produced in p38K keratinocytes, albeit in diminished amounts, may still have functional importance. Moreover, MMP13 expression in other cell types, such as dermal fibroblasts and myeloid cells, is likely intact in p38K skin; MMP13 produced from these alternative cellular sources could compensate the loss of keratinocyte-derived MMP13. ) mice had a systemic deficiency of MMP13 (48) . These mice were in a C57BL/6J background and maintained in specific pathogen-free conditions. All animal experiments were conducted under an Institutional Animal Care and Use Committee-approved protocol.
MATERIALS AND METHODS
Mice
Primary cells and cell lines
Primary mouse keratinocytes isolated from the skin of C57BL/6 newborn mice and primary human keratinocytes (a gift from G. P. Dotto) were cultured as described (49, 50) . KERT cells (a gift from A. Mandinova; originally from the American Type Culture Collection) and 293T cells were cultured in keratinocyte-SFM and Dulbecco's modified Eagle's medium (both from Thermo Fisher Scientific), respectively.
Keratinocyte colony formation
Pinnae of 10-to 12-week-old mice were separated into dorsal and ventral halves and incubated with trypsin (0.5%; Thermo Fisher Scientific) for 1 hour and then with deoxyribonuclease I (10 U/ml; Sigma-Aldrich) for 20 min at 37°C. Keratinocytes thus isolated were plated at a density of 10 5 cell/ml in a six-well plate and grown in CnT-07 medium (CELLnTEC) for 10 days with medium changed every other day. Keratinocyte colonies were visualized by crystal violet staining.
Clinical tissue samples
Cases with a diagnosis of AK and SCC were identified from the Massachusetts General Hospital pathology archives. Deidentified AK/SCC sections were prepared and provided by the Massachusetts General Hospital Dermatopathology Unit.
Reagents DMBA, TPA, BrdU, cycloheximide, 5Z-7-oxozeaenol, and verapamil were from Sigma-Aldrich; MG132, anisomycin, SB202190, and SC409 were from EMD Millipore; D-JNKi was from BML; and murine IL-1 was from R&D Systems. Antibodies against the following proteins were used in immunoblotting after 1:1000 dilution: p38 (sc-535) and p63 4A4 (sc-8431; both from Santa Cruz Biotechnology); p-p38 (9211), p-MK2 (3007), and p-Ser 66/68 -p63 (4981; all from Cell Signaling Technology); p-Ser 301 -p63 (PA5-39827) and p-Ser 361 -p63 (PA5-38380; both from Thermo Fisher Scientific); and actin (A4700; Sigma-Aldrich). Antibodies specific to the following proteins were used in immunofluorescence staining after 1:50 to 1:1000 dilution: p38 (sc-535), p63 H-137 (sc-8343), and p63 4A4 (sc-8431; all from Santa Cruz Biotechnology); p-p38 (9211) and p-Ser 66/68 -p63 (4981; both from Cell Signaling Technology); Ki67 (ab16667) and MMP13 (ab39012; both from Abcam); KRT14 (PRB-155P) and KRT15 (PCK-153P; both from Covance); CD3e (SP7) and KRT1 (ab9286; both from Abcam); and Ly6G/Gr-1 (553125; BD Biosciences). Hoechst 33324 and antibodies conjugated with Alexa Fluor 488 or Alexa Fluor 595 were from Molecular Probes.
Chemical carcinogenesis and TPA-induced inflammation
Shaved dorsal back skin of 8-to 10-week-old mice was subjected to a single treatment of topical DMBA (100 g) for tumor initiation and semiweekly treatment of topical TPA (10 g) for 20 weeks for tumor promotion (18) . The first treatment with TPA was 1 week after DMBA exposure. To induce acute skin inflammation, shaved dorsal back skin was treated with TPA (10 g) daily for 2 consecutive days; inflamed skin was analyzed 2 days later.
Punch-biopsy wound healing
Shaved and depilated dorsal skin of 7-to 8-week-old mice was subjected to full-thickness wounding (epidermis to panniculus carnosus) using a 4-mm biopsy punch. Each wound circle was digitally photographed, and the wound area was calculated using Adobe Photoshop.
BrdU label retention
Ten-day-old mice were injected with BrdU (50 mg/kg) every 12 hours for a total of four injections; skin was collected after a chase period of 15 days to analyze epidermal BrdU + cells.
Side population discrimination assay
Keratinocytes from the pinna of 10-to 12-week-old mice were incubated with Hoechst 33324 (5 g/ml) for 1 hour, washed with icecold phosphate-buffered saline, stained with propidium iodide (1 g/ml), and analyzed using Fortessa X-20 (BD Biosciences) and FlowJo (Tree Star).
Plasmid transfection and lentiviral transduction
Plasmid vectors expressing hemagglutinin-tagged p38 and p38 CA (gifts from D. Engelberg), MKK6 EE (a gift from J. Han), and FLAGtagged Np63 (Addgene) were used in 293T cell transfection using Lipofectamine 2000 (Thermo Fisher Scientific). Lentiviral vectors expressing Np63 and its variants were constructed using the backbone vector pCDH-CMV-MCS-EF1-copGFP (System Biosciences). To generate Np63 variants harboring amino acid substitutions, mutations were introduced into the coding sequence using GeneArt Site-Directed Mutagenesis System (Thermo Fisher Scientific). Mouse p63-specific shRNA constructs (TRCN0000012749 and TRCN0000423330; Thermo Fisher Scientific) were among the RNAi Consortium clones. The human p63-specific shRNA construct was specific to 5′-acacacatggtatccagatgac-3′ in TP63. Lentiviral vectors expressing mouse and human p63-specific shRNA were based on pLKO.1. Lentiviral particles were generated by 293T cell transfection and quantified using the QuickTiter Lentivirus Titer Kit (Cell Biolabs). Keratinocytes were infected with lentiviruses in the presence of polybrene (8 g/ml) for 4 hours and used for subsequent analyses 2 days later.
Histology and immunofluorescence
Mouse skin/tumor tissues and human AK/SCC biopsies were fixed with formalin and embedded in paraffin. Tissue sections were analyzed by H&E staining or by immunofluorescence using marker-specific primary antibodies, Alexa Fluor 488/595-conjugated secondary antibodies, and Hoechst 33324. BrdU in tissue sections was analyzed using the BrdU In Situ Detection Kit (BD Biosciences).
Protein and RNA analysis
Whole-cell lysates were prepared and analyzed by immunoblotting as described (51) . For in vitro kinase reactions, recombinant p38 and Np63 proteins fused with glutathione S-transferase (SignalChem) were incubated in a reaction buffer containing [- 32 P]ATP at 30°C for 30 min and analyzed by SDS-PAGE and autoradiography. To map phosphorylated Np63 residues, SDS-PAGE-separated and Coomassie Blue-stained proteins were subjected to trypsin or chymotrypsin digestion and mass spectrometry [liquid chromatography-tandem mass spectrometry (LC-MS/MS); the BIDMC Mass Spectrometry Facility]. Total RNA was isolated using the RNeasy Mini Kit (Qiagen) and analyzed by real-time qPCR using gene-specific primers (table S2) . DNA microarray analysis was performed using GeneChip Mouse Genome 430 2.0 Array (Affymetrix) and the GENE-E matrix visualization and analysis platform (Broad Institute).
TCGA data analysis TCGA data (clinical, mRNA sequencing, and RPPA) were downloaded from the GDAC Firehose, the cBioPortal for Cancer Genomics, and the Cancer Proteome Atlas Portal. Survival analysis of patient groups with differential RPPA signals was performed using GraphPad Prism.
Statistical analysis
Data values are expressed as means ± SD unless indicated otherwise. P values were obtained by the unpaired two-tailed Student's t test, the Mann-Whitney test, and the log-rank (Mantel-Cox) test.
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